Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • lexogen
    Registered Vendor
    • Aug 2012
    • 49

    RiboCop - An efficient way of rRNA depletion by Lexogen

    Lexogen is happy to announce release of a new RiboCop rRNA Depletion Kit. This is a very cost efficient protocol for elimination of cytoplasmic as well as mitochondrial ribosomal RNA from human, mouse and rat samples. RiboCop has very simple workflow and does not require any enzymatic reactions. Obtained total RNA is ready for NGS library preparation.

    Learn more and request your trial kit on the RiboCop web page: https://www.lexogen.com/ribocop-rrna-depletion-kit/

    Do not hesitate contacting us should you have any questions at [email protected] or +43 1345 12 12 41
  • lexogen
    Registered Vendor
    • Aug 2012
    • 49

    #2
    RiboCop has been upgraded!

    Several months ago we successfully launched the RiboCop kit for depletion of cytoplasmic and mitochondrial ribosomal RNA in Human, Mouse and Rat samples. In this short period, the protocol has brought a lot of positive feedback from users due to its high efficiency, simplicity and cost saving features. Moreover, some of our customers had special technical requests which they asked us to implement into the existing protocol for excelling their experiments. We have accommodated the major wishes and we are happy to release the new version of RiboCop under the name RiboCop V1.2.

    Learn what’s new: https://www.lexogen.com/upgrade-of-r...depletion-kit/

    As usual, we will keep advancing our products to meet all your needs!

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM
    • SEQadmin2
      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
      by SEQadmin2



      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
      07-08-2026, 05:17 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 07-20-2026, 11:10 AM
    0 responses
    18 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-13-2026, 10:26 AM
    0 responses
    32 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-09-2026, 10:04 AM
    0 responses
    43 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-08-2026, 10:08 AM
    0 responses
    29 views
    0 reactions
    Last Post SEQadmin2  
    Working...